Compugen (CGEN) Tops Q4 EPS by 10c

Compugen (NASDAQ: CGEN) reported Q4 EPS of ($0.01), $0.10 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $8.3 million versus the consensus estimate of $3.33 million.

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance
• Byline Bancorp (BY) Tops Q1 EPS by 6c